Independent at heart: persistent association of altitude with ischaemic heart disease mortality after consideration of climate, topography and built environment

Journal of Epidemiology and Community Health
David FaehSwiss National Cohort Study Group

Abstract

Living at higher altitude was dose-dependently associated with lower risk of ischaemic heart disease (IHD). Higher altitudes have different climatic, topographic and built environment properties than lowland regions. It is unclear whether these environmental factors mediate/confound the association between altitude and IHD. We examined how much of the altitude-IHD association is explained by variations in exposure at place of residence to sunshine, temperature, precipitation, aspect, slope and distance to main road. We included 4.2 million individuals aged 40-84 at baseline living in Switzerland at altitudes 195-2971 m above sea level (ie, full range of residence), providing 77 127 IHD deaths. Mortality data 2000-2008, sociodemographic/economic information and coordinates of residence were obtained from the Swiss National Cohort, a longitudinal, census-based record linkage study. Environment information was modelled to residence level using Weibull regression models. In the model not adjusted for other environmental factors, IHD mortality linearly decreased with increasing altitude resulting in a lower risk (HR, 95% CI 0.67, 0.60 to 0.74) for those living >1500 m (vs<600 m). This association remained after adjustment for all ot...Continue Reading

References

Jun 1, 1979·American Journal of Epidemiology·R W BuechleyM V Morgan
Jan 1, 1993·European Journal of Applied Physiology and Occupational Physiology·E A KollerJ Kohl
Jan 12, 2001·Journal of Epidemiology and Community Health·K E Pickett, M Pearl
Aug 21, 2001·Journal of Epidemiology and Community Health·A Torres
Oct 25, 2002·High Altitude Medicine & Biology·Aleksey N Tin'kov, Valeriy A Aksenov
Dec 10, 2003·Controlled Clinical Trials·Kevin J Carroll
Mar 16, 2005·Journal of Epidemiology and Community Health·Nikos BaibasDimitrios Trichopoulos
Apr 20, 2007·Respiratory Physiology & Neurobiology·B Ostadal, F Kolar
Sep 1, 2007·The Journal of Physiology·M Faadiel Essop
Mar 11, 2008·International Journal of Epidemiology·Matthias BoppMatthias Egger
Sep 9, 2008·Scandinavian Journal of Medicine & Science in Sports·P Bärtsch, B Saltin
Apr 24, 2009·Journal of Epidemiology and Community Health·D FaehUNKNOWN Swiss National Cohort Study Group
Jul 29, 2009·Circulation·David FaehUNKNOWN Swiss National Cohort Study Group
Jun 18, 2010·International Journal of Public Health·Adrian SpoerriMatthias Bopp
Aug 3, 2010·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·D FaehM Bopp
Sep 23, 2010·BMC Public Health·Matthias BoppUNKNOWN Swiss National Cohort Study Group
Jun 22, 2012·Journal of Epidemiology and Community Health·Radoslaw PanczakUNKNOWN Swiss National Cohort and Swiss Household Panel
Jan 4, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Abdias HurtadoRichard J Johnson
Mar 16, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Judith MaagUNKNOWN Swiss National Cohort
May 11, 2013·European Journal of Epidemiology·Radoslaw PanczakMatthias Egger
Aug 12, 2014·Aging and Disease·Martin Burtscher

❮ Previous
Next ❯

Citations

Jul 5, 2016·Frontiers in Physiology·Gregoire P MilletOlivier Girard
Jun 26, 2018·High Altitude Medicine & Biology·Jainy J SavlaHesham A Sadek
Jul 8, 2017·Circulation Research·Aruni Bhatnagar
Feb 3, 2018·Clinical and Experimental Hypertension : CHE·Valeria HirschlerLuis A Castano
Jan 12, 2019·AIMS Public Health·Valeria HirschlerClaudio Gonzalez
Aug 15, 2020·Frontiers in Physiology·Norina N GassmannKaspar Staub
Aug 25, 2017·Respiratory Research·Andreas HornerUNKNOWN PREPOCOL Study Group
Nov 30, 2018·Frontiers in Endocrinology·Amaya Lopez-PascualPedro González-Muniesa
Jun 23, 2020·Journal of Obesity·Ray M Merrill
Sep 15, 2020·BioMed Research International·Agnieszka Zembron-LacnyMiłosz Czuba
Apr 6, 2021·Cardiology Research and Practice·Hirofumi TeradaMichiaki Yamakage
Mar 17, 2021·Revue des maladies respiratoires·S Baillieul, J Brugniaux
May 27, 2021·Antioxidants & Redox Signaling·Amaya Lopez-PascualPedro González-Muniesa
Aug 8, 2021·International Journal of Molecular Sciences·Jaslyn JohnsonSteven R Houser
Sep 2, 2017·Environment International·Danielle VienneauUNKNOWN SNC Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.